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Abstract
Background: Pseudosarcomatous myofibroblastic lesions of the urinary bladder are relatively
rare entities of an uncertain pathogenesis and benign indolent nature.
Case presentation: We present an extremely rare case of an ALK-1-positive
pseudosarcomatous myofibroblastic lesion of the urinary bladder, which was initially
misinterpreted as a low-grade leiomyosarcoma of myxoid subtype on histologic examination owing
to prominent atypia, high mitotic activity, abnormal mitotic figures and infiltration of the bladder
wall. Although the histologic features were suggestive of a sarcoma, the correct diagnosis was finally
established and radical surgical treatment was subsequently avoided. The patient is currently free
of disease without any evidence of tumor recurrence or metastasis at 3 years post-operatively.
Conclusion: The key differentiating point rests in distinguishing the aforementioned mass forming
lesion from the myxoid subtype of low-grade leiomyosarcoma in order to avoid unnecessary radical
therapy.
Introduction
Non-epithelial tumors account for 2%–5% of all primary
urinary bladder neoplasms, with the most common types
being rhabdomyosarcoma in patients under the age of 10
years and leiomyosarcoma in adults. The latter has 3 dis-
tinct histologic variants: the classical spindle cell subtype,
the myxoid subtype and the less frequent epithelioid sub-
type [1,2]. The key differentiating point rests in distin-
guishing the myxoid subtype of low-grade
leiomyosarcoma from pseudosarcomatous myofibroblas-
tic proliferation, which is a rare entity of benign indolent
nature, in order to avoid unnecessary radical therapy [1].
Herein, we report on an extremely rare case of a pseudosa-
rcomatous myofibroblastic lesion of the urinary bladder
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that displayed prominent atypia and discuss its pathogen-
esis, histology, differential diagnosis, biologic behavior
and pertinent treatment.
Case presentation
A 36-year-old, postpartum, white female became increas-
ingly symptomatic with sharp, low abdominal pain with
the completion of each urination and gross hematuria.
She denied night sweats or fever and any history of urinary
tract infection, trauma, instrumentation or other urologi-
cal problems. An ultrasound study of the kidneys and the
urinary bladder revealed a broad-based polypoid mass
(2.4 × 2.3 × 2.2 cm), located in the right posterolateral
wall of the bladder. The patient subsequently underwent
a transurethral resection of the aforementioned lesion.
Histologic examination of the excised mass displayed
infiltration of the bladder wall (Fig. 1) by an atypical spin-
dle cell proliferation with histologic features of myofi-
broblasts (Fig. 2) arranged in sheets with focal myxoid
areas (Fig. 3), whereas the overlying transitional epithe-
lium was normal (Fig. 4). In particular, the tumor cells
demonstrated prominent nucleoli and nuclear pleomor-
phism; numerous normal mitotic figures (5/10hpf) and a
few abnormal ones were seen. By immunohistochemical
evaluation, the cells were: (a) positive for vimentin and
ALK-1 (Fig 5); (b) focally positive for cytokeratins 8/18/
19, muscle specific and smooth muscle actins, and
desmin; (c) negative for S-100, CD34, c-Kit (CD117), h-
caldesmon and MyoD1.
These histologic findings posed a particular diagnostic
problem and yielded a differential diagnosis of pseudosa-
rcomatous myofibroblastic lesion versus low-grade leio-
myosarcoma of focally myxoid type. Although the
possibility of the former was taken into account, the diag-
nosis of malignancy could not be avoided, given the
nuclear pleomorphism, abnormal mitoses and the infil-
trative nature of the lesion. Based on the absence of an in
situ urothelial neoplasm and the immunophenotype, this
Lesional cells extending between bundles of smooth muscle  (hematoxylin-eosin ×200) Figure 1
Lesional cells extending between bundles of smooth 
muscle (hematoxylin-eosin ×200).
An area of loose spindle-shaped cells, displaying elongated  cytoplasmic processes and slight nuclear atypia, in a myxoid  background (hematoxylin-eosin ×400) Figure 2
An area of loose spindle-shaped cells, displaying elon-
gated cytoplasmic processes and slight nuclear aty-
pia, in a myxoid background (hematoxylin-eosin 
×400).
Fascicular arrangement and compact cellularity containing  inflammatory infiltrate and conspicuous mitoses (hematoxy- lin-eosin ×200) Figure 3
Fascicular arrangement and compact cellularity con-
taining inflammatory infiltrate and conspicuous 
mitoses (hematoxylin-eosin ×200).Diagnostic Pathology 2008, 3:11 http://www.diagnosticpathology.org/content/3/1/11
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was considered to be more likely a smooth muscle tumor
than a spindle cell carcinoma. Consequently, further ade-
quate local excision was recommended. At that point, a
staging work-up, including a bone scan, abdominal/pelvic
MRIs and an intravaginal ultrasound, disclosed no defi-
nite evidence of radiographically residual intravesicular
tumor and no evidence of extension or metastasis. Due to
negative staging work-up and considering the rarity and
complexity of the case, the patient was referred for close
clinical follow-up and cystoscopic re-evaluation of the
bladder excision site for potential residual lesion.
After five months' interval since the initial transurethral
resection, a repeat cystoscopy was performed and dis-
closed scar tissue without any obvious tumor growth;
additional biopsies were obtained from the surgical site.
Microscopy revealed no sarcoma, but residual foci that
simulated a reactive process.
Given that a sarcoma of the bladder would have already
shown significant proliferative activity and comparing the
initial slides with the re-biopsy slides, we issued a new
diagnosis; in particular, we inclined more towards a diag-
nosis of pseudosarcomatous myofibroblastic lesion
instead of a sarcoma. Due to the atypical features encoun-
tered and the fact that the biological potential of this
entity cannot be accurately assessed, a close follow-up was
warranted. The patient did not receive any adjuvant treat-
ment. She is currently free of disease without evidence of
tumor recurrence or metastasis by 3-year follow-up.
Discussion
Non-neoplastic reactive, mesenchymal proliferation of
the urinary bladder is a rare, but distinctive entity, which
has been referred to as inflammatory pseudotumor (IP) or
myofibroblastic tumor (IMT), postoperative spindle cell
nodule, nodular fasciitis, pseudosarcomatous myofibrob-
lastic proliferation, pseudomalignant spindle cell prolifer-
ation, and pseudosarcomatous or atypical fibromyxoid
tumor [3,4]. The unifying feature of these lesions is their
tendency to mimic both sarcomas and spindled carcino-
mas, thus presenting particular diagnostic difficulties in
urinary bladder pathology.
The pathogenesis of IMT is still in doubt [4]; some regard
this entity as a reactive or inflammatory condition, while
others believe that it represents a low-grade mesenchymal
malignancy. The latter endorse the low-grade neoplastic
nature of this entity owing to (a) the occurrence of cases
with deep infiltration of the bladder wall and extension
into the perivesical soft tissue and (b) the demonstration
of a non-random chromosomal translocation involving
2p23 that results in the expression of anaplastic lym-
phoma kinase (ALK) [5]. In addition, the relationship of
bladder IMT to lesions called IMT in other anatomic sites
remains uncertain [3,6], since bladder lesions are far more
likely to express keratin, probably less likely to recur and
certainly less likely to metastasize than the latter [3];
albeit, they share similar morphologic features and
molecular alterations with these [3,7].
Pseudosarcomatous myofibroblastic tumor exhibiting spindle  cells arranged in fascicles with a myxoid stroma and inflam- matory cells Figure 4
Pseudosarcomatous myofibroblastic tumor exhibit-
ing spindle cells arranged in fascicles with a myxoid 
stroma and inflammatory cells. Note the intact over-
lying urothelial mucosa (hematoxylin-eosin ×200).
The ALK-1 immunostain demonstrates diffuse cytoplasmic  positivity in the lesional cells (immunoperoxidase ×400) Figure 5
The ALK-1 immunostain demonstrates diffuse cyto-
plasmic positivity in the lesional cells (immunoperox-
idase ×400).Diagnostic Pathology 2008, 3:11 http://www.diagnosticpathology.org/content/3/1/11
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Pseudosarcomatous myofibroblastic lesions of the blad-
der may occur at any age (range from childhood to elderly
patients), but typically occur in adult males [3,8,9]; being
in contrast to other reports [10-12] that support a female
preponderance. These rare lesions have a non-specific
presentation with painless gross hematuria being the
most common presenting symptom; other complaints
include dysuria, frequency, suprapubic pain, or the dis-
covery of a mass lesion. Their size is quite variable, rang-
ing from a few centimeters up to a reported size of 37.5 cm
[9]. Endoscopically and radiographically, these cannot be
distinguished from malignant tumors [13]. Cystoure-
throscopy reveals either an intraluminal (exophytic or
polypoid) mass or a submucosal (mural) lesion that may
be easily overlooked [10]. When the tumor is sectioned,
the mass is relatively gelatinous and soft [11] or has a pale,
firm cut surface [10,14] without areas of hemorrhage or
necrosis.
IMT contains a mixture of spindle cells showing myofi-
broblastic differentiation, admixed with variable numbers
of inflammatory cells. These display 3 histologic patterns
in varying proportions: (a) the myxoid-vascular pattern,
characterized by loosely arranged, stellate-to-plump spin-
dle cells in an oedematous, myxoid background with an
irregular network of small blood vessels and inflamma-
tory cells, resembling nodular fasciitis or granulation tis-
sue, (b) the compact spindle cell pattern, which consists
of a compact interlacing fascicular or storiform spindle
cell proliferation with variable myxoid and collagenized
regions, accompanied by an inflammatory infiltrate com-
posed largely of plasma cells, resembling fibrous histiocy-
toma or smooth muscle neoplasms, (c) the hypocellular-
fibrous pattern, characterized by platelike collagen, lower
cellularity and relatively sparse inflammation with lym-
phocytes and plasma cells trapped in a dense eosinophilic
matrix, resembling a desmoid or scar [15,16]. Microscop-
ically, the lesional spindle cells are bipolar with elon-
gated, eosinophilic cytoplasmic processes, which are
devoid of cross-striations, and central oval nuclei charac-
terized by smooth nuclear contours, open chromatin pat-
tern, occasional nucleoli and lack of unequivocal
malignant features [10,11]. Anaplastic or pleomorphic
features as well as atypical or bizzare mitotic figures are
absent; occasional mitoses may be found but the mitotic
activity is typically low [11]. Some lesions demonstrate
compact cellularity with mitoses, necrosis and bladder
wall invasion [3].
Of clinical importance, IMT follows a benign indolent
course and conservative management (complete transure-
thral resection or partial cystectomy) has been reported
[1,3,13,17] as treatment of choice. Additional close fol-
low-up (surveillance cystoscopy and biopsy to document
resolution) is advised for most cases [3,18] due to the fact
that the biological potential of this entity cannot be accu-
rately assessed and its histologic similarity to malignant
neoplasms. Moreover, it is critical not to misdiagnose IMT
as rhabdomyosarcoma, leiomyosarcoma or sarcomatoid
urothelial carcinoma in order to avoid inappropriate rad-
ical surgery and/or adjuvant therapy and their attendant
complications.
In fact, some leiomyosarcomas of the urinary bladder can
express cytokeratin and are partially or extensively myxoid
to such a degree that distinction from IMTs may become
impossible; albeit, the presence of (a) prominent cytolog-
ical atypia, (b) abnormal mitotic figures, (c) preferential
reactivity for high-molecular-weight caldesmon and the
lack of (a) a delicate vascular network, (b) interspersed
inflammatory and red blood cells, and (c) ALK-1 immu-
nostaining (usually demonstrated in IMT) may be of par-
ticular value in the differential diagnosis [1,3-5,14,19,20].
Similarly, sarcomatoid urothelial carcinomas sometimes
show weak or focal immunoreactivity for cytokeratin and
display myxoid features leading to potential diagnostic
confusion with IMT. Of note, the identification of an in
situ or invasive "typical" epithelial component usually
allows for their diagnosis; other supportive features in
favour of sarcomatoid urothelial carcinomas include
prominent cytological atypia, atypical mitoses, non-
myxoid areas with marked increased cellularity and usu-
ally ALK-1 negativity [3,14]. With regard to embryonal
rhabdomyosarcomas in the pediatric setting, these can be
distinguished from IMTs by (a) exhibiting greater cellular-
ity and increased numbers of atypical mitotic figures, (b)
the presence of rhabdomyoblasts, a uniform population
of small hyperchromatic cells, (c) a "cambium layer"
(small malignant cells characteristically grouped beneath
the epithelium) and (d) positive myogenin (Myf4) and
MyoD1 immunostainings [5,11,19,20].
Immunohistochemically, it has become apparent that h-
caldesmon, myogenin and ALK-1, in contrast to muscle
specific and smooth muscle actins, desmin and cytokera-
tin, can be of great value in the differential diagnosis of
vesical IMTs [4,14,20]. As far as ALK-1 cytoplasmic expres-
sion is concerned, this has been identified in a range of
8% to 89% of IMT cases in the urinary bladder [20] and in
the current report as well; albeit being suggestive of a neo-
plastic rather than a reactive or inflammatory nature and
consistent with abundant mitoses and prominent atypia,
the present ALK-positive lesion has neither recurred nor
metastasized 3 years post-operatively.
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